Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-008529
Filing Date
2023-08-07
Accepted
2023-08-07 10:30:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 28970
2 filename2.txt TEXT-EXTRACT 3981
  Complete submission text file 0000000000-23-008529.txt   44869
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filed for) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations